Search
Search Results
-
Fractal analysis of left ventricular trabeculae in post-STEMI: from acute to chronic phase
PurposeThe temporal evolution of ventricular trabecular complexity and its correlation with major adverse cardiovascular events (MACE) remain...
-
ST-segment elevation myocardial infarction heart of Charlotte one-year (STEMI HOC-1) study: a prospective study protocol
BackgroundST-segment elevation myocardial infarction (STEMI) is a clinically distinguishable yet lethal sequela of ischaemic heart disease (IHD). In...
-
Predictive value of systemic immune-inflammation index combined with N-terminal pro-brain natriuretic peptide for contrast-induced acute kidney injury in patients with STEMI after primary PCI
ObjectiveTo investigate the relationship between the incidence of contrast-induced acute kidney injury (CI-AKI) after emergency percutaneous coronary...
-
FITT-STEMI: Qualitätsverbesserung in der Herzinfarktversorgung
Background and objectiveIt is often not possible to achieve the treatment times stipulated in guidelines in patients with acute ST-elevation...
-
Perspective/Commentary: The Transformation of STEMI Care with Thrombolysis in Paramedicine
The integration of thrombolysis into paramedicine practice has brought about a significant paradigm shift in the treatment and prognosis of patients...
-
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis
The precise role of Lipoprotein associated phospholipase A2 (Lp-PlA2) in the pathogenesis of acute coronary syndromes (ACS) and in the prediction of...
-
The prognostic value of dynamic changes in SII for the patients with STEMI undergoing PPCI
BackgroundPredicting the prognosis of primary percutaneous coronary intervention(PPCI) in ST-segment elevation myocardial infarction (STEMI) patients...
-
Empagliflozin Effects in Patients with ST-Elevation Myocardial Infarction Undergoing Primary PCI: The EMI-STEMI Randomized Clinical Trial
IntroductionEmpagliflozin, a sodium-glucose cotransporter 2 (SGLT2) inhibitor, improves cardiovascular outcomes in heart failure patients, but data...
-
COVID-19 pandemic affects STEMI numbers and in-hospital mortality: results of a nationwide analysis in Germany
BackgroundThe COVID-19 pandemic led to extensive restrictions in Germany in 2020, including the postponement of elective interventions. We examined...
-
Prognosis value of serum soluble ST2 level in acute ischemic stroke and STEMI patients in the era of mechanical reperfusion therapy
BackgroundSoluble form suppression of tumorigenicity 2 (sST2) is known to have prognostic value in ST-elevation myocardial infarction (STEMI) and...
-
The ability and optimal cutoff value of serum cell division cycle 42 in estimating major adverse cardiac event in STEMI patients treated with percutaneous coronary intervention
Cell division cycle 42 (CDC42) regulates cholesterol efflux, chronic inflammation, and reendothelialization in various atherosclerotic diseases. This...
-
Discussion on the causes of thrombolysis failure in a patient with STEMI: a case report
BackgroundSpontaneous coronary artery dissection (SCAD) has emerged as an increasingly diagnosed cause of ST-segment elevation myocardial infarction...
-
STEMI: Considerations for Left Main Culprit Lesions
Purpose of ReviewThere is a paucity of data regarding the prevalence, clinical characteristics, and outcomes of patients presenting with ST elevation...
-
-
Delayed PCI is not beneficial for STEMI patients with impaired renal function: a retrospective cohort study
BackgroundPreexisting impaired renal function (IRF) and contrast-induced nephropathy (CIN) after percutaneous coronary intervention (PCI) in patients...
-
Direct comparison of coronary microvascular obstruction evaluation using CMR feature tracking and layer-specific speckle tracking echocardiography in STEMI patients
PurposeLayer-specific speckle tissue echocardiography (LS-STE) is a unique technique used to assess coronary microvascular obstruction (CMVO) that...
-
SYSTEMI - systemic organ communication in STEMI: design and rationale of a cohort study of patients with ST-segment elevation myocardial infarction
BackgroundST-segment elevation myocardial infarction (STEMI) still causes significant mortality and morbidity despite best-practice revascularization...
-
Mitigating the risk of flow deterioration by deferring stent optimization in STEMI patients with large thrombus burden: Insights from a prospective cohort study
ObjectivesIt is uncertain, if omitting post-dilatation and stent oversizing (stent optimization) is safe and may decrease the risk for distal...
-
Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
Antithrombotic therapy is the cornerstone of pharmacological treatment in patients undergoing primary percutaneous coronary intervention (PCI)....
-
Time to ECG diagnosis delays inter-hospital transfer to revascularization in STEMI patients presenting to a regional emergency department: a five-year audit
BackgroundReducing the door-to-balloon time (D2BT) in ST-elevation myocardial infarction (STEMI) patients maximizes myocardial salvage and mitigates...
